Urologische Klinik

Degarelix for treating advanced hormone-sensitive prostate cancer (2021) Zengerling F, Jakob JJ, Schmidt S, Meerpohl JJ, Blumle A, Schmucker C, Mayer B, Kunath F Journal article Training and work conditions of residents in urology in Germany Results of the second German Society of Residents in Urology e. V. (GeSRU) residency survey from 2020 (2021) Arnold H, Fassbach M, Mattigk A, Zehe , Beck A, Wundrack F, Konig J, et al. Journal article Prognostic impact of molecular muscle-invasive bladder cancer subtyping approaches and correlations with variant histology in a population-based mono-institutional cystectomy cohort (2021) Weyerer V, Stöhr R, Bertz S, Lange F, Geppert CI, Wach S, Taubert H, et al. Journal article Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer Patients (2021) Eckstein M, Lieb V, Jung R, Sikic D, Weigelt K, Stöhr R, Geppert CI, et al. Journal article GeSRU Virtual GeSRU Meetings and Webinars as Part of the Regional Congresses (2021) Mattigk A, Wishahi M, Wundrack FM, Siech C, Bellut L Journal article, Editorial High androgen receptor mrna expression is associated with improved outcome in patients with high-risk non-muscle-invasive bladder cancer (2021) Sikic D, Taubert H, Wirtz RM, Breyer J, Eckstein M, Weyerer V, Kubon J, et al. Journal article The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents (2021) Dürr P, Schlichtig K, Kelz C, Deutsch B, Maas R, Eckart MJ, Wilke J, et al. Journal article Abdominal Panniculectomy Can Simplify Kidney Transplantation in Obese Patients (2021) Promny D, Hauck T, Cai A, Arkudas A, Heller KM, Wullich B, Apel H, et al. Journal article Bladder tumor subtype commitment occurs in carcinoma in-situ driven by key signaling pathways including ECM remodeling (2021) Wullweber A, Strick R, Lange F, Sikic D, Taubert H, Wach S, Wullich B, et al. Conference contribution Thrombospondin‐2 and ldh are putative predictive biomarkers for treatment with everolimus in second‐line metastatic clear cell renal cell carcinoma (Marc‐2 study) (2021) Zeuschner P, Hölters S, Stöckle M, Seliger B, Mueller A, Bachmann HS, Grünwald V, et al. Journal article